A rating of 27 puts Revance Therapeutics Inc (RVNC) near the bottom of the Biotechnology industry according to InvestorsObserver. Revance Therapeutics Inc's score of 27 means it scores higher than 27% of stocks in the industry. Revance Therapeutics Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 20 out of the 148 industries.
RVNC has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on RVNC!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Revance Therapeutics Inc Stock Today?
Revance Therapeutics Inc (RVNC) stock is trading at $4.72 as of 2:23 PM on Monday, Mar 25, a drop of -$0.15, or -3.1% from the previous closing price of $4.87. The stock has traded between $4.65 and $5.02 so far today. Volume today is less active than usual. So far 877,651 shares have traded compared to average volume of 2,079,117 shares.
Click Here to get the full Stock Report for Revance Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
